Recall archive / FDA drug enforcement

Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA... — FDA record D-0850-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Aug 17, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Reason: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Classification: Class I
Recalling firm: Baxter Healthcare Corporation
Quantity: 606 bags
Agency-reported status: Ongoing
Source record identifier: D-0850-2026

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot #: Y495066, Exp. Date July 31, 2027

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

U.S. Nationwide.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: Sep 16, 2026
Recall initiation date: Aug 17, 2026
Center classification date: Sep 15, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.